Development of a Motivational Intervention to Improve Treatment Adhere
Development of a Motivational Intervention to Improve Treatment Adherence in MS
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Motivational Interviewing-Cognitive Behavioral Therapy
Given to everyone in the trial
- Brief Education
What it measured
Main measures
Adherence Treatment Survey
10 weeks after enrollment
Quality of life (reported by participants)
Other measures (2)
Adherence Treatment Survey
10 weeks after enrollment
Quality of life (reported by participants)Adherence Treatment Survey
5 weeks after enrollment
Quality of life (reported by participants)
Who could take part
Relapsing MS · 18 and over
Show the full criteria
Inclusion criteria
* Diagnosis of relapsing remitting MS based on established guidelines * Previously discontinued recommended therapy * Provider recommendation for DMT re-initiation * At least 18 years of age * Access to a telephone * English speaking
Exclusion criteria
* Diagnosis other than relapsing remitting MS * Provider does not recommend DMT re-initiation * Pregnant or breastfeeding (females)
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
As many as 50% of MS patients prematurely discontinue their disease modifying medications. For this study, we will develop a telephone-based talk therapy intervention and then conduct a randomized controlled trial. Patients will be assigned to either 5 weekly 20 minute telephone sessions of psychotherapy or a brief education control condition. We hypothesize that patients undergoing phone therapy will be more likely to indicate they are interested in resuming taking disease modifying medications than patients given brief education and treatment as usual.
Papers
Loading reviews and guidelines…
History
Started
Feb 2013
Main results due
Apr 2015
Finished
Sept 2015